Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J COLEBATCH

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Clinical Chemistry|February 1, 2018
Optimizing Amplification of the GC-Rich <i>TERT</i> Promoter Region Using 7-Deaza-dGTP for Droplet Digital PCR Quantification of <i>TERT</i> Promoter MutationsAndrew J Colebatch, Tom Witkowski, Paul M Waring, et al.
Pathology|June 17, 2023
NTRK fusions in solid tumours: what every pathologist needs to knowMinh Anh Nguyen, Andrew J Colebatch, Diana Van Beek, et al.
Pediatric Dermatology|November 5, 2021
Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in childrenStefanie Haefliger, Pascale Guitera, Bruna Melhoranse Gouveia, et al.
ANZ Journal of Surgery|August 29, 2012
Remote frozen section examination of breast sentinel lymph nodes by telepathologyAndrew J Gifford, Andrew J Colebatch, Shahram Litkouhi, et al.
Pathology|March 6, 2022
Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanomaAndrew J Colebatch, Elizabeth C Paver, Ismael A Vergara, et al.
Oncotarget|September 10, 2016
Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignanciesAndrew J Colebatch, Leon Di Stefano, Stephen Q Wong, et al.
The American Journal of Surgical Pathology|November 20, 2019
Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in PregnancyLouise A Jackett, Andrew J Colebatch, Robert V Rawson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 4, 2015
Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanomaJames S Wilmott, Andrew J Colebatch, Hojabr Kakavand, et al.
Pathology|October 27, 2021
ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1Timothy Fielder, Jordan Butler, Geraldine Tierney, et al.
Pathology|July 1, 2023
Inter-rater concordance of basal cell carcinoma subtypes: influences on reporting format and opportunities for further classification modificationsNigel G Maher, Natasha Prosser, Karina Aivazian, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Clinical Chemistry|February 1, 2018
Optimizing Amplification of the GC-Rich <i>TERT</i> Promoter Region Using 7-Deaza-dGTP for Droplet Digital PCR Quantification of <i>TERT</i> Promoter MutationsAndrew J Colebatch, Tom Witkowski, Paul M Waring, et al.
Pathology|June 17, 2023
NTRK fusions in solid tumours: what every pathologist needs to knowMinh Anh Nguyen, Andrew J Colebatch, Diana Van Beek, et al.
Pediatric Dermatology|November 5, 2021
Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in childrenStefanie Haefliger, Pascale Guitera, Bruna Melhoranse Gouveia, et al.
ANZ Journal of Surgery|August 29, 2012
Remote frozen section examination of breast sentinel lymph nodes by telepathologyAndrew J Gifford, Andrew J Colebatch, Shahram Litkouhi, et al.
Pathology|March 6, 2022
Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanomaAndrew J Colebatch, Elizabeth C Paver, Ismael A Vergara, et al.
Oncotarget|September 10, 2016
Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignanciesAndrew J Colebatch, Leon Di Stefano, Stephen Q Wong, et al.
The American Journal of Surgical Pathology|November 20, 2019
Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in PregnancyLouise A Jackett, Andrew J Colebatch, Robert V Rawson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 4, 2015
Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanomaJames S Wilmott, Andrew J Colebatch, Hojabr Kakavand, et al.
Pathology|October 27, 2021
ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1Timothy Fielder, Jordan Butler, Geraldine Tierney, et al.
Pathology|July 1, 2023
Inter-rater concordance of basal cell carcinoma subtypes: influences on reporting format and opportunities for further classification modificationsNigel G Maher, Natasha Prosser, Karina Aivazian, et al.
Pageof 9